Your browser doesn't support javascript.
loading
Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ.
O'Shea, Anne E; Clifton, Guy T; Qiao, Na; Heckman-Stoddard, Brandy M; Wojtowicz, Malgorzata; Dimond, Eileen; Bedrosian, Isabelle; Weber, Diane; Garber, Judy E; Husband, Alexander; Pastorello, Ricardo; Lee, J Jack; Hernandez, Mike; Liu, Diane D; Vornik, Lana A; Brown, Powel H; Alatrash, Gheath; Peoples, George E; Mittendorf, Elizabeth A.
Affiliation
  • O'Shea AE; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas.
  • Clifton GT; Department of Surgery, Brooke Army Medical Center, Ft. Sam Houston, Texas.
  • Qiao N; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heckman-Stoddard BM; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Wojtowicz M; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Dimond E; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland.
  • Bedrosian I; Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Weber D; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Husband A; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
  • Pastorello R; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lee JJ; Harvard Medical School, Boston, Massachusetts.
  • Hernandez M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Liu DD; Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Vornik LA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, Massachusetts.
  • Brown PH; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Alatrash G; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Peoples GE; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Mittendorf EA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer Prev Res (Phila) ; 16(6): 333-341, 2023 06 01.
Article de En | MEDLINE | ID: mdl-37259799

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome intracanalaire non infiltrant / Vaccins anticancéreux Type d'étude: Clinical_trials Limites: Female / Humans Langue: En Journal: Cancer Prev Res (Phila) Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome intracanalaire non infiltrant / Vaccins anticancéreux Type d'étude: Clinical_trials Limites: Female / Humans Langue: En Journal: Cancer Prev Res (Phila) Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article